George A. Scangos, Director at Vir Biotechnology, Inc. (VIR), sold 55,500 shares at $10.22 ($568K) on 2024-02-20, disclosed to the SEC on 2024-02-20.
Scheduled sale ($568k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.24 | 10,878 | $111K | 19.6% |
| 2 | $10.24 | 10,878 | $111K | 19.6% |
| 3 | $10.22 | 16,872 | $172K | 30.4% |
| 4 | $10.22 | 16,872 | $172K | 30.4% |
| Total | $10.23 avg | 55,500 | $568K | 100% |
| Filing → |
| VIR | SELL | 2024-02-26 | $614K | — | Filing → |
| VIR | SELL | 2023-02-24 | $1.4M | — | Filing → |
| VIR | SELL | 2023-02-21 | $1.5M | — | Filing → |